Regulating Mental Health Telemedicine: Cross-Jurisdictional Challenges and Policy Responses

Mental health telemedicine has expanded at unprecedented scale since 2020, transforming psychiatric and psychological services from predominantly in-person to hybrid digital delivery. This transformation has exposed the inadequacy of regulatory frameworks originally designed for face-to-face clinical encounters. This paper offers a comparative analysis of the regulation of mental-health telemedicine in India, the United States, and the United Kingdom. It examines licensing, standard of care, informed consent, data protection, cross-border practice, and emergency-protocol requirements, drawing on India's Telemedicine Practice Guidelines 2020 and Mental Healthcare Act 2017, the US Ryan Haight Online Pharmacy Consumer Protection Act 2008 and state telehealth statutes, and the UK's General Medical Council Remote Prescribing Guidance 2020 and Data Protection Act 2018. The analysis engages the recent contribution of P and Venkateswarlu (2025) and identifies three convergent trends—standard-of-care equivalence, data-minimization mandates, and suicide-risk protocols and three areas of persistent divergence—licensing portability, controlled-substance prescribing, and cross-border provider accountability. The paper proposes a tiered international framework to reconcile patient mobility with regulatory coherence.